Keywords: irbesartan, japan, shionogi, pharmaceutical, collaborate, bristol-myers, squibb
Irbesartan In Japan
Article | 27 May 1996
- Shionogi Pharmaceutical is to collaborate with Bristol-Myers Squibb for the development of Sanofi's angiotensin II antagonist irbesartan, a drug for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
